You are here

Article Text

Article menu
Download PDFPDF
Original article
The continuous glucose monitoring sensor in neonatal intensive care
  1. K Beardsall1,
  2. A L Ogilvy-Stuart1,
  3. J Ahluwalia1,
  4. M Thompson2,
  5. D B Dunger1
  1. 1University of Cambridge, Department of Paediatrics, Addenbrooke’s Hospital, and Neonatal Unit, Rosie Maternity Hospital, Cambridge, UK
  2. 2Luton and Dunstable Hospital, Lewsey Road, Luton, UK
  1. Correspondence to:
    Dr Beardsall
    University of Cambridge, Department of Paediatrics, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, UK; kb274cam.ac.uk

Abstract

Objective: To determine the feasibility of continuous glucose monitoring in the very low birthweight baby requiring intensive care, as these infants are known to be at high risk of abnormalities of glucose control.

Method: Sixteen babies were studied from within 24 hours of delivery and for up to seven days.

Results: The subcutaneous glucose sensors were well tolerated and readings were comparable to those on near patient whole blood monitoring devices.

Conclusion: Continuous glucose monitoring is practical in neonates, giving detailed information about glucose control.

  • CGMS, continuous glucose monitoring sensor
  • CI, confidence interval
  • VLBW, very low birth weight
  • glucose monitoring
  • very low birth weight
  • prematurity

https://doi.org/10.1136/adc.2004.051979

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests: Medtronic supplied the CGMS monitors

    Linked Articles

    • Fantoms
      Fantoms
      Martin Ward Platt
      Archives of Disease in Childhood - Fetal and Neonatal Edition 2005; 90 F283-FF283 Published Online First: 21 Jun 2005.